$56.9 Million is the total value of Polaris Venture Management Co IV LLC's 4 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XLRN | Sell | Acceleron Pharma Inc | $36,853,000 | -38.3% | 1,480,060 | -21.6% | 64.78% | +4.3% |
| PULM | Pulmatrix Inc | $7,816,000 | -48.9% | 1,591,862 | 0.0% | 13.74% | -13.6% | |
| ALIM | Alimera Sciences Inc | $6,958,000 | -52.1% | 3,148,355 | 0.0% | 12.23% | -19.0% | |
| CERU | Cerulean Pharma Inc | $5,261,000 | -20.4% | 1,437,441 | 0.0% | 9.25% | +34.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Acceleron Pharma Inc | 12 | Q3 2016 | 85.9% |
| Alimera Sciences Inc | 12 | Q3 2016 | 16.4% |
| Cerulean Pharma Inc | 10 | Q3 2016 | 10.8% |
| Pulmatrix Inc | 6 | Q3 2016 | 15.9% |
| TechTarget Inc | 2 | Q1 2014 | 8.1% |
View Polaris Venture Management Co IV LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2020-05-06 |
| 3 | 2020-04-30 |
| 4 | 2018-04-05 |
| 13F-HR | 2017-02-14 |
| 13F-HR | 2017-02-14 |
| 13F-HR | 2016-05-13 |
| 13F-HR | 2016-02-16 |
| 13F-HR | 2015-11-10 |
| 13F-HR | 2015-08-11 |
| 4/A | 2015-06-25 |
View Polaris Venture Management Co IV LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.